News
In this episode of the Applied Clinical Trials Brief, Shipra Patel, global therapeutic area section head for endocrinology ...
Eli Lilly has shared positive results from the Phase III BRUIN CLL-313 clinical trial (NCT05023980) evaluating Jaypirca (pirtobrutinib) versus chemoimmunotherapy (bendamustine plus rituximab) in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback